← back to search

Shiyang Li

Shandong University · CN
Area of research
Molecular Biology · Spectroscopy
Research interest
Research focused on Sphingolipid and Aryl hydrocarbon receptor, with related work in Cell biology, Bile acid, Innate lymphoid cell. Notable publications include 'The Aryl Hydrocarbon Receptor Preferentially Marks and Promotes Gut Regulatory T Cells', 'TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response', and 'Ikaros Inhibits Group 3 Innate Lymphoid Cell Development and Function by Suppressing the Aryl Hydrocarbon Receptor Pathway'.
h-index
citations
370
works
8
NIH funding
primary concept
email

Recent publications

Development and validation of universal PCR, basic ERA, and qPCR assays targeting the 16S-23S rRNA intergenic spacer region for Mycoplasma detection
Microbial Pathogenesis 2025cited by 1position: middledoi
TNF compromises intestinal bile-acid tolerance dictating colitis progression and limited infliximab response
Cell Metabolism 2024cited by 54position: lastdoi
m6A modification-tuned sphingolipid metabolism regulates postnatal liver development in male mice
Nature Metabolism 2023cited by 36position: middledoi
Bile acid-dependent transcription factors and chromatin accessibility determine regional heterogeneity of intestinal antimicrobial peptides
Nature Communications 2023cited by 21position: middledoi
A multifunctional enolase mediates cytoadhesion and interaction with host plasminogen and fibronectin in Mycoplasma hyorhinis
Veterinary Research 2022cited by 38position: middledoi
m6A modification-tuned sphingolipid metabolism regulates postnatal liver development
Research Square 2022cited by 1position: middledoi
The Aryl Hydrocarbon Receptor Preferentially Marks and Promotes Gut Regulatory T Cells
Cell Reports 2017cited by 171position: middledoi
Ikaros Inhibits Group 3 Innate Lymphoid Cell Development and Function by Suppressing the Aryl Hydrocarbon Receptor Pathway
Immunity 2016cited by 48position: firstdoi

Grants

No grants ingested yet.

Frequent collaborators

Lixiang Li · Shandong University3 papers (2023–2024)Cuijuan Zhang · Shandong University3 papers (2022–2024)Mathias Heikenwälder · German Cancer Research Center3 papers (2022–2024)Detian Yuan · Shandong University2 papers (2023–2024)Yanfei Yu · Jiangsu University2 papers (2022–2025)Bowen Xu · Shandong University2 papers (2022–2023) · 2 papers (2022–2025)Shuzheng Chu · Shandong University2 papers (2023–2024)Ping Mi · Shandong University2 papers (2022–2023)Youquan Zhong · Jiangxi University of Traditional Chinese Medicine2 papers (2022–2023)Yuchen Xia · Technical University of Munich2 papers (2022–2023)Xiuli Zuo · Shandong University2 papers (2023–2024)Xiaoyun Yang · Shandong University2 papers (2023–2024)Yanbo Yu · Space Science Institute2 papers (2023–2024)Zhixin Feng · Hebei Medical University2 papers (2022–2025)John W. Bostick · University of Florida2 papers (2016–2017)Zaichao Xu · Dalian Medical University2 papers (2022–2023)Bingcheng Feng · Shandong University2 papers (2023–2024)Liang Zhou · Northwestern University2 papers (2016–2017) · 2 papers (2016–2017)